Sree Kant Email and Phone Number
New York, NY, US
Sree Kant's Location
New York, New York, United States, United States
Sree Kant's Contact Details
Sree Kant work email
- Valid
- Valid
- Valid
- Valid
Sree Kant personal email
n/a
Sree Kant phone numbers
About Sree Kant
Life Sciences thought leader and executive. Founder & ex-ceo of BAKX Therapeutics; Former head of Corporate Development at Life Biosciences; Former head of partnering strategy for Pfizer. Former healthcare principal at Boston Consulting.
Sree Kant's Current Company Details
Sree Kant Work Experience Details
-
Co-Founder, President And CeoCelsiege Biosciences Inc.New York, Ny, Us
-
Founder & Chief Executive OfficerBakx Therapeutics Inc Jun 2020 - PresentNew York | Boston, Us
-
Founder & Managing DirectorBearsville Partners Llc Feb 2020 - Present
-
Head Of Business DevelopmentLife Biosciences Jul 2018 - Jan 2020Boston, Massachusetts, Us- Oversaw Investments, strategic partnerships, R&D portfolio strategy, company creation, M&A and R&D models for Life Biosciences.- Built strategic investment thesis for Life Bio investments, and led the Scientific and Strategic evaluation of investment opportunities --> supporting 8 portfolio company investments made by Life in areas of Autophagy, Senescence, Metabolic dysfunction, DNA repair, Genetic reprogramming, Iron Channel modulation, AI, and Animal health- Led all partnering activities as the Chief Business Officer for Life portfolio companies - partnering conversations with pharma, strategic partners, and investors, in various stages for research collaborations, and licensing/acquisitions- Evaluated scope/opportunities for use of AI at Life for target discovery, and lead generation, using proprietary and public ageing data - As member of Life executive team, drove and supported the strategic direction of Life and its portfolio companies --> incl. portfolio review and prioritization of Life portfolio investments – leading to focus on three core platforms – Autophagy, Mitochondrial dysfunction, and Genetic reprogramming - Actively supported Life capital raising efforts --> incl. $50M series B and ongoing series C- Represented Life bio at various avenues as speaker and panelist on subjects of new business models and novel investment paradigms in ageing, longevity research, partnering structures, etc. -
Head - Strategic Partnerships, External Science & InnovationPfizer Aug 2015 - Jul 2018New York, New York, Us- Strategic leadership build in key science areas – e.g., led the creation of Pfizer’s Gene Therapy leadership strategy, culminating in key acquisitions/partnerships - Innovative scouting/partnership concepts to access deal flow from Europe and Asia – e.g., judicious use of incubator investments, strategic syndicates with VCs/ banks for co-investments and sharing deal flow- Creation of Pfizer’s Innovative Target Exploration Network (ITEN) and reshaping of Pfizer’s Centers for Therapeutic Innovation (CTI) --> e.g., UTSW target exploration partnership with Beutler Lab, UK research collaboration on Deubiquitination across Oxford, Cambridge, and the Crick, Autophagy collaborations with UCSF- Strategic partnerships with VCs and Contract Research Organizations to share risk and extend Pfizer’s discovery capabilities – supported creation of Pfizer’s early stage investment fund, R&Dnnovate- Built Pfizer’s R&D asset externalization strategy (including support of ‘SpringWorks’ spinoff)- Positioned Pfizer as the “Partner-of-Choice” with biotech, academia, state, and foundations --> developing a coordinated strategy involving thoughtful use of sponsorships, scientific meetings, and partnering events across the globe -
Portfolio Strategy Lead (Worldwide Research & Development)Pfizer Sep 2012 - Aug 2015New York, New York, Us- Created a Therapeutic area investment thesis given the overall risk, cost, competition, portfolio position, and deal availability for each strategic Pfizer TA --> adopted into R&D business planning and Therapeutic Area Strategy- Rethink of the R&D development path -including (i) systematic early data generation to enable a smaller but higher quality portfolio; and (ii) instituting associated portfolio metrics and targets- Comprehensive cost analysis of internally developed portfolio v/s externally sourced portfolio --> leading to a more informed approach in Pfizer’s external partnership stance and strategy- Detailed attrition analysis in Pfizer’s portfolio --> leading to a re-characterization of Pfizer’s attrition capture model, increased focus on pharmacology and Phase 2 attrition, and new guidelines on project kill/advancement
-
PrincipalThe Boston Consulting Group Jun 2006 - Jun 2012Boston, Massachusetts, UsGrowth Strategy/New business: - Created a growth plan for a large diversified healthcare company with ambition to add $16B in growth by 2020 (included scan of overall healthcare space and value pools in 2020 in conjunction with existing/needed capabilities)- Helped a MedTech company enter a new business of pre-filled syringes for generic injectables (included full market evaluation of opportunity, competitor analysis, and creation of business plan)Developed a 5-year growth strategy for a leading supplier to biopharma companies through new business creation (including detailed implementation planning)◊ a potential ~$3B revenue increase Corporate Development: - Supported corporate development efforts for a large pharma company as part of a SWAT team seconded to the company (included financial and strategic valuation of potential acquisitions – companies, products, and novel technologies)- Supported Post Merger Integration of a merger of two large pharmacos; Led integration design and implementation of Toxicology and ADME functions --> leading to overall cost synergies of ~ $3B Commercial Operations- Restructured the managed care group of a large Pharma company to position them for success in a changing healthcare environment --> included assessment of evolving payer needs and better alignment of resources across key customers -
Manager - Strategy, Licensing & Business DevelopmentRanbaxy Laboratories Limited Jun 2000 - Dec 2001Gurgaon, Haryana, In- Supported Ranbaxy’s entry strategy into France (culminating in the $84M RPG-Aventis deal)- Supported critical operations for Ranbaxy, UK, as part of an interim 4-member restructuring team
Sree Kant Skills
Strategy
Management Consulting
Business Strategy
Pharmaceutical Industry
Corporate Development
Strategic Consulting
Management
Biotechnology
Competitive Analysis
Market Entry
Analytics
Financial Modeling
Leadership
Business Transformation
Organizational Design
Mergers And Acquisitions
Healthcare
Growth Strategies
Sree Kant Education Details
-
Harvard UniversityInternational Health -
Indian Institute Of Management BangaloreBusiness Administration
-
Bangalore University, Bms College Of EngineeringElectronics And Communications Engineering
Frequently Asked Questions about Sree Kant
What company does Sree Kant work for?
Sree Kant works for Celsiege Biosciences Inc.
What is Sree Kant's role at the current company?
Sree Kant's current role is Co-Founder, President and CEO.
What is Sree Kant's email address?
Sree Kant's email address is sr****@****ard.edu
What is Sree Kant's direct phone number?
Sree Kant's direct phone number is +121257*****
What schools did Sree Kant attend?
Sree Kant attended Harvard University, Indian Institute Of Management Bangalore, Bangalore University, Bms College Of Engineering.
What skills is Sree Kant known for?
Sree Kant has skills like Strategy, Management Consulting, Business Strategy, Pharmaceutical Industry, Corporate Development, Strategic Consulting, Management, Biotechnology, Competitive Analysis, Market Entry, Analytics, Financial Modeling.
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial